Agenda Topics- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- Mobile Diagnostics Devices
- Wearable and Implantable Devices
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateSebastien Bergeron, Founder and CEO, Parallex BioAssays Inc. James Boiani, Partner, Epstein Becker & Green, P.C. Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital, Harvard Medical School Samantha Byrnes, Research Scientist, Intellectual Ventures Laboratory Lars Dähne, Founder & Managing Director, Surflay Nanotec GmbH Karolien De Wael, Full Professor, Antwerp University Reuven Duer, Founder & CEO, Proactive Diagnostics, Inc. Maarten Fauvart, R&D Team Leader / Senior Scientist Life Science Technologies, IMEC Chris Fronczek, Director of Applications, BIODOT, Inc. Rosanne Guijt, Professor, Deakin University Vincent Linder, Founder and President, CDP BioMedical Consulting and CEO at Calciscon AG Marloes Peeters, Deputy Director of Chemical Engineering, Newcastle University Michael Schöning, Professor and Director, Institute of Nano- and Biotechnologies, Aachen University of Applied Sciences Jean-Manuel Segura, Professor, University of Applied Sciences and Arts Western Switzerland Valais Barbara Smith, Assistant Professor, School of Biological and Health Systems Engineering, Arizona State University E. Brandon Strong, NSF Graduate Research Fellow, California Polytechnic State University, San Luis Obispo Winnie Svendsen, Professor, Technical University of Denmark Erik Vollebregt, Partner, Axon Lawyers Patrick Wagner, Professor, Soft-Matter Physics and Biophysics Section, Departement Natuurkunde en Sterrenkunde, Katholieke Universiteit Leuven
|